39959-72-3 Usage
Uses
Used in Pharmaceutical Industry:
Alpha-Cyclopropylbenzylamine hydrochloride is used as a precursor in the synthesis of pharmaceutical drugs for its ability to interact with various receptors in the body, contributing to the development of new medications for different medical conditions.
Used in Agrochemical Industry:
alpha-Cyclopropylbenzylamine hydrochloride is also utilized as a building block in the synthesis of agrochemicals, playing a crucial role in the development of novel compounds for agricultural applications.
Used in Organic Chemistry Research:
Alpha-Cyclopropylbenzylamine hydrochloride is employed as a research tool in organic chemistry, aiding scientists in exploring new chemical reactions and pathways, which could lead to the discovery of innovative drug compounds and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 39959-72-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,9,5 and 9 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 39959-72:
(7*3)+(6*9)+(5*9)+(4*5)+(3*9)+(2*7)+(1*2)=183
183 % 10 = 3
So 39959-72-3 is a valid CAS Registry Number.
39959-72-3Relevant academic research and scientific papers
QUINOLINE 4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS NEUROKININ 3 (NK-3) RECEPTOR ANTAGONISTS
-
Page/Page column 25, (2010/02/10)
The invention relates to novel quinoline derivatives, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments particularly in treating disorders of the central nervous system (CNS).
Anthranilamides and methods of their use
-
, (2008/06/13)
The present invention is related to anthranilamides of formula I, in which R(1) to R(7) have the meanings indicated herein, a process for their preparation, their use as medicaments, and pharmaceutical preparations containing them. The compounds act on the Kv1.5 potassium channel and inhibit a potassium current which is referred to as the ultra-rapidly activating delayed rectifier in the atrium of the human heart. The compounds are therefore suitable for use as novel antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias (e.g., atrial fibrillation (AF) or atrial flutter).
